151 related articles for article (PubMed ID: 8063042)
21. Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic, and insulin-treated diabetic rats.
Hardin DS; Dominguez JH; Garvey WT
Metabolism; 1993 Oct; 42(10):1310-5. PubMed ID: 8412743
[TBL] [Abstract][Full Text] [Related]
22. Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man.
Koranyi LI; Bourey RE; Vuorinen-Markkola H; Koivisto VA; Mueckler M; Permutt MA; Yki-Järvinen H
Diabetologia; 1991 Oct; 34(10):763-5. PubMed ID: 1959709
[TBL] [Abstract][Full Text] [Related]
23. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
24. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.
Vestergaard H; Weinreb JE; Rosen AS; Bjørbaek C; Hansen L; Pedersen O; Kahn BB
J Clin Endocrinol Metab; 1995 Jan; 80(1):270-5. PubMed ID: 7829624
[TBL] [Abstract][Full Text] [Related]
25. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.
Schalin-Jäntti C; Härkonen M; Groop LC
Diabetes; 1992 May; 41(5):598-604. PubMed ID: 1568529
[TBL] [Abstract][Full Text] [Related]
26. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.
Nyholm B; Mengel A; Nielsen S; Skjaerbaek C; Møller N; Alberti KG; Schmitz O
Diabetologia; 1996 Jul; 39(7):813-22. PubMed ID: 8817106
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice.
Marshall BA; Mueckler MM
Am J Physiol; 1994 Nov; 267(5 Pt 1):E738-44. PubMed ID: 7977725
[TBL] [Abstract][Full Text] [Related]
29. Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families.
Jackson S; Bagstaff SM; Lynn S; Yeaman SJ; Turnbull DM; Walker M
Diabetes; 2000 Jul; 49(7):1169-77. PubMed ID: 10909975
[TBL] [Abstract][Full Text] [Related]
30. Effects of altered glucose homeostasis on glucose transporter expression in skeletal muscle of the rat.
Bourey RE; Koranyi L; James DE; Mueckler M; Permutt MA
J Clin Invest; 1990 Aug; 86(2):542-7. PubMed ID: 2384600
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity.
Ebeling P; Bourey R; Koranyi L; Tuominen JA; Groop LC; Henriksson J; Mueckler M; Sovijärvi A; Koivisto VA
J Clin Invest; 1993 Oct; 92(4):1623-31. PubMed ID: 8408617
[TBL] [Abstract][Full Text] [Related]
32. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle.
Camps M; Castelló A; Muñoz P; Monfar M; Testar X; Palacín M; Zorzano A
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):765-72. PubMed ID: 1554359
[TBL] [Abstract][Full Text] [Related]
33. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.
Forsblom CM; Eriksson JG; Ekstrand AV; Teppo AM; Taskinen MR; Groop LC
Diabetologia; 1995 Mar; 38(3):363-9. PubMed ID: 7758885
[TBL] [Abstract][Full Text] [Related]
34. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.
Johnson JH; Ogawa A; Chen L; Orci L; Newgard CB; Alam T; Unger RH
Science; 1990 Oct; 250(4980):546-9. PubMed ID: 2237405
[TBL] [Abstract][Full Text] [Related]
35. Exercise reduces muscle glucose transport protein (GLUT-4) mRNA in type 1 diabetic patients.
Koivisto VA; Bourey RE; Vuorinen-Markkola H; Koranyi L
J Appl Physiol (1985); 1993 Apr; 74(4):1755-60. PubMed ID: 8514693
[TBL] [Abstract][Full Text] [Related]
36. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture.
Koivisto UM; Martinez-Valdez H; Bilan PJ; Burdett E; Ramlal T; Klip A
J Biol Chem; 1991 Feb; 266(4):2615-21. PubMed ID: 1990010
[TBL] [Abstract][Full Text] [Related]
38. Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Alford F; Vaag A; Handberg A; Beck-Nielsen H
Metabolism; 1999 Sep; 48(9):1128-35. PubMed ID: 10484052
[TBL] [Abstract][Full Text] [Related]
39. Regulation of glucose transport in skeletal muscle.
Barnard RJ; Youngren JF
FASEB J; 1992 Nov; 6(14):3238-44. PubMed ID: 1426762
[TBL] [Abstract][Full Text] [Related]
40. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart.
Paternostro G; Clarke K; Heath J; Seymour AM; Radda GK
Cardiovasc Res; 1995 Aug; 30(2):205-11. PubMed ID: 7585807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
